Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Immunological responses in mice to full-thickness corneal grafts engineered from porcine collagen.

Liu L, Kuffová L, Griffith M, Dang Z, Muckersie E, Liu Y, McLaughlin CR, Forrester JV.

Biomaterials. 2007 Sep;28(26):3807-14. Epub 2007 Apr 24.

PMID:
17537502
2.

Crosslinked collagen hydrogels as corneal implants: effects of sterically bulky vs. non-bulky carbodiimides as crosslinkers.

Ahn JI, Kuffova L, Merrett K, Mitra D, Forrester JV, Li F, Griffith M.

Acta Biomater. 2013 Aug;9(8):7796-805. doi: 10.1016/j.actbio.2013.04.014. Epub 2013 Apr 22.

PMID:
23619290
3.

A simple, cross-linked collagen tissue substitute for corneal implantation.

Liu Y, Gan L, Carlsson DJ, Fagerholm P, Lagali N, Watsky MA, Munger R, Hodge WG, Priest D, Griffith M.

Invest Ophthalmol Vis Sci. 2006 May;47(5):1869-75.

PMID:
16638993
4.

Effect of αGal on corneal xenotransplantation in a mouse model.

Choi HJ, Kim MK, Lee HJ, Jeong SH, Kang HJ, Park CS, Park CG, Joon Kim S, Wee WR.

Xenotransplantation. 2011 May-Jun;18(3):176-82. doi: 10.1111/j.1399-3089.2011.00641.x.

PMID:
21696447
6.
7.

ACAID induced by allogeneic corneal tissue promotes subsequent survival of orthotopic corneal grafts.

Sonoda A, Sonoda Y, Muramatu R, Streilein JW, Usui M.

Invest Ophthalmol Vis Sci. 2000 Mar;41(3):790-8.

PMID:
10711695
8.

Recombinant human collagen for tissue engineered corneal substitutes.

Liu W, Merrett K, Griffith M, Fagerholm P, Dravida S, Heyne B, Scaiano JC, Watsky MA, Shinozaki N, Lagali N, Munger R, Li F.

Biomaterials. 2008 Mar;29(9):1147-58.

PMID:
18076983
9.

[Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant].

Shi W, Xie L, Wang S.

Zhonghua Yan Ke Za Zhi. 2002 Aug;38(8):502-5. Chinese.

PMID:
12410993
10.

[Biocompatibility of acellular corneal stroma and transplantation of tissue-engineered corneal epithelium].

Fang XF, Zhao J, Shi WY, Xie LX.

Zhonghua Yan Ke Za Zhi. 2008 Oct;44(10):934-42. Chinese.

PMID:
19176124
11.

Role of donor-specific cytotoxic T cells in rejection of corneal allografts in normal and high-risk eyes.

Ksander BR, Sano Y, Streilein JW.

Transpl Immunol. 1996 Mar;4(1):49-52.

PMID:
8762010
12.

Kinetics of leukocyte and myeloid cell traffic in the murine corneal allograft response.

Kuffová L, Lumsden L, Veselá V, Taylor JA, Filipec M, Holán V, Dick AD, Forrester JV.

Transplantation. 2001 Oct 15;72(7):1292-8.

PMID:
11602858
13.
14.

Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells.

Sonoda KH, Taniguchi M, Stein-Streilein J.

J Immunol. 2002 Feb 15;168(4):2028-34.

16.

Regeneration of corneal cells and nerves in an implanted collagen corneal substitute.

McLaughlin CR, Fagerholm P, Muzakare L, Lagali N, Forrester JV, Kuffova L, Rafat MA, Liu Y, Shinozaki N, Vascotto SG, Munger R, Griffith M.

Cornea. 2008 Jun;27(5):580-9. doi: 10.1097/ICO.0b013e3181658408.

PMID:
18520509
17.

Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.

Yamada J, Kurimoto I, Streilein JW.

Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2614-21.

PMID:
10509657
18.

Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber.

Yamada J, Streilein JW.

Invest Ophthalmol Vis Sci. 1997 Dec;38(13):2833-43.

PMID:
9418737
19.

Xenoreactive CD4+ T cells and acute rejection of orthotopic guinea pig corneas in mice.

Tanaka K, Yamada J, Streilein JW.

Invest Ophthalmol Vis Sci. 2000 Jun;41(7):1827-32.

PMID:
10845605
20.

[CTLA4-Ig prevents corneal allograft rejection in mice].

Shi WY, Xie LX.

Zhonghua Yan Ke Za Zhi. 2004 Oct;40(10):696-700. Chinese.

PMID:
16200862

Supplemental Content

Support Center